Back
Eupraxia Pharmaceuticals Inc. EPRX · Insights
Eupraxia Pharmaceuticals Inc., a clinical-stage biotechnology company, focuses on the development of... Price7.42
Market Cap492.2 M
Float63.26 M
CountryCA
SectorHealthcare
ExchangeNASDAQ
OverviewFilingsInsightsDilutionNewsTranscriptsInsights are a pro only featureUpgrade now to access key point-in-time insights for this ticker. We have shown an example insight below.Upgrade to Pro Insights are a pro only featureUpgrade now to access key point-in-time insights for this ticker. We have shown an example insight below.Upgrade to Pro